FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4207079592> ?p ?o ?g. }

• W4207079592 endingPage "e31308" @default.
• W4207079592 startingPage "e31308" @default.
• W4207079592 abstract "Background Approximately one-third of all concussions lead to persistent postconcussion syndrome (PPCS). Repetitive transcranial magnetic stimulation (rTMS) is a form of noninvasive brain stimulation that has been extensively used to treat refractory major depressive disorder and has a strong potential to be used as a treatment for patients with PPCS. Functional near-infrared spectroscopy (fNIRS) has already been used as a tool to assess patients with PPCS and may provide insight into the pathophysiology of rTMS treatment in patients with PPCS. Objective The primary objective of this research is to determine whether rTMS treatment improves symptom burden in patients with PPCS compared to sham treatment using the Rivermead postconcussion symptom questionnaire. The secondary objective is to explore the neuropathophysiological changes that occur following rTMS in participants with PPCS using fNIRS. Exploratory objectives include determining whether rTMS treatment in participants with PPCS will also improve quality of life, anxiety, depressive symptoms, cognition, posttraumatic stress, and function secondary to headaches. Methods A total of 44 adults (18-65 years old) with PPCS (>3 months to 5 years) will participate in a double-blind, sham-controlled, concealed allocation, randomized clinical trial. The participants will engage in either a 4-week rTMS treatment protocol or sham rTMS protocol (20 treatments). The left dorsolateral prefrontal cortex will be located through Montreal Neurologic Institute coordinates. The intensity of the rTMS treatment over the left dorsolateral prefrontal cortex will be 120% of resting motor threshold, with a frequency of 10 Hz, 10 trains of 60 pulses per train (total of 600 pulses), and intertrain interval of 45 seconds. Prior to starting the rTMS treatment, participant and injury characteristics, questionnaires (symptom burden, quality of life, depression, anxiety, cognition, and headache), and fNIRS assessment will be collected. Repeat questionnaires and fNIRS will occur immediately after rTMS treatment and at 1 month and 3 months post rTMS. Outcome parameters will be analyzed by a 2-way (treatment × time) mixed analysis of variance. Results As of May 6, 2021, 5 participants have been recruited for the study, and 3 have completed the rTMS protocol. The estimated completion date of the trial is May 2022. Conclusions This trial will expand our knowledge of how rTMS can be used as a treatment option of PPCS and will explore the neuropathophysiological response of rTMS through fNIRS analysis. Trial Registration ClinicalTrials.gov NCT04568369; https://clinicaltrials.gov/ct2/show/NCT04568369 International Registered Report Identifier (IRRID) DERR1-10.2196/31308" @default.
• W4207079592 created "2022-01-26" @default.
• W4207079592 creator A5005274633 @default.
• W4207079592 creator A5016935850 @default.
• W4207079592 creator A5036047127 @default.
• W4207079592 creator A5045273192 @default.
• W4207079592 creator A5067202681 @default.
• W4207079592 creator A5068397692 @default.
• W4207079592 date "2022-03-22" @default.
• W4207079592 modified "2023-09-24" @default.
• W4207079592 title "Treatment of Persistent Postconcussion Syndrome With Repetitive Transcranial Magnetic Stimulation Using Functional Near-Infrared Spectroscopy as a Biomarker of Response: Protocol for a Randomized Controlled Clinical Trial" @default.
• W4207079592 cites W150096504 @default.
• W4207079592 cites W1948961139 @default.
• W4207079592 cites W1964327301 @default.
• W4207079592 cites W1967278483 @default.
• W4207079592 cites W1973374859 @default.
• W4207079592 cites W2000697043 @default.
• W4207079592 cites W2002197146 @default.
• W4207079592 cites W2007029142 @default.
• W4207079592 cites W2008342744 @default.
• W4207079592 cites W2011026399 @default.
• W4207079592 cites W2012225431 @default.
• W4207079592 cites W2025564775 @default.
• W4207079592 cites W2034408057 @default.
• W4207079592 cites W2043705607 @default.
• W4207079592 cites W2046496887 @default.
• W4207079592 cites W204766049 @default.
• W4207079592 cites W2049265876 @default.
• W4207079592 cites W2061668357 @default.
• W4207079592 cites W2073522591 @default.
• W4207079592 cites W2089355229 @default.
• W4207079592 cites W2090020945 @default.
• W4207079592 cites W2105644370 @default.
• W4207079592 cites W2107595901 @default.
• W4207079592 cites W2108112020 @default.
• W4207079592 cites W2111066106 @default.
• W4207079592 cites W2125189318 @default.
• W4207079592 cites W2127457454 @default.
• W4207079592 cites W2132586977 @default.
• W4207079592 cites W2134151866 @default.
• W4207079592 cites W2134578184 @default.
• W4207079592 cites W2139478705 @default.
• W4207079592 cites W2146814325 @default.
• W4207079592 cites W2154660651 @default.
• W4207079592 cites W2156104108 @default.
• W4207079592 cites W2174561539 @default.
• W4207079592 cites W2208872697 @default.
• W4207079592 cites W2300190440 @default.
• W4207079592 cites W2507367097 @default.
• W4207079592 cites W2536632246 @default.
• W4207079592 cites W2554488711 @default.
• W4207079592 cites W2562220447 @default.
• W4207079592 cites W2587726926 @default.
• W4207079592 cites W2627009404 @default.
• W4207079592 cites W2737370566 @default.
• W4207079592 cites W2739412554 @default.
• W4207079592 cites W2756841235 @default.
• W4207079592 cites W2786591984 @default.
• W4207079592 cites W2797082979 @default.
• W4207079592 cites W2800691390 @default.
• W4207079592 cites W2889198882 @default.
• W4207079592 cites W2896261224 @default.
• W4207079592 cites W2898834153 @default.
• W4207079592 cites W2902153077 @default.
• W4207079592 cites W2912913855 @default.
• W4207079592 cites W2919550154 @default.
• W4207079592 cites W2931955613 @default.
• W4207079592 cites W2940610098 @default.
• W4207079592 cites W2944710603 @default.
• W4207079592 cites W2956753577 @default.
• W4207079592 cites W2980881910 @default.
• W4207079592 cites W2984937892 @default.
• W4207079592 cites W2987667961 @default.
• W4207079592 cites W3012617116 @default.
• W4207079592 cites W3089672375 @default.
• W4207079592 cites W3105672604 @default.
• W4207079592 doi "https://doi.org/10.2196/31308" @default.
• W4207079592 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35315783" @default.
• W4207079592 hasPublicationYear "2022" @default.
• W4207079592 type Work @default.
• W4207079592 citedByCount "3" @default.
• W4207079592 countsByYear W42070795922022 @default.
• W4207079592 countsByYear W42070795922023 @default.
• W4207079592 crossrefType "journal-article" @default.
• W4207079592 hasAuthorship W4207079592A5005274633 @default.
• W4207079592 hasAuthorship W4207079592A5016935850 @default.
• W4207079592 hasAuthorship W4207079592A5036047127 @default.
• W4207079592 hasAuthorship W4207079592A5045273192 @default.
• W4207079592 hasAuthorship W4207079592A5067202681 @default.
• W4207079592 hasAuthorship W4207079592A5068397692 @default.
• W4207079592 hasBestOaLocation W42070795921 @default.
• W4207079592 hasConcept C118552586 @default.
• W4207079592 hasConcept C126322002 @default.
• W4207079592 hasConcept C130796691 @default.
• W4207079592 hasConcept C15744967 @default.
• W4207079592 hasConcept C168563851 @default.
• W4207079592 hasConcept C169900460 @default.
• W4207079592 hasConcept C1862650 @default.

• next